![]() |
市場調查報告書
商品編碼
1954590
全球眼科超音波市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Ophthalmic Ultrasound Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球眼科超音波市場規模為3.0373億美元。預計該市場將從2026年的3.2519億美元成長到2034年的5.7855億美元,在預測期(2026-2034年)內複合年增長率(CAGR)為7.47%。北美地區引領全球眼科超音波市場,預計到2025年將佔42.34%的市場佔有率,這主要得益於其先進的醫療基礎設施和眼部疾病盛行率的上升。
眼科超音波設備是一種專業的影像診斷系統,它利用高頻聲波來觀察眼內結構,例如視網膜、玻璃體、前節和眼眶。該設備對於診斷青光眼、糖尿病視網膜病變、老年黃斑部病變、玻璃體出血和視網膜剝離等疾病至關重要。
市場驅動因素
眼部疾病盛行率上升
眼部疾病負擔日益加重是推動市場成長的主要因素。根據2025年3月發布的數據,預計到2025年底,全球約有30.6%的成年人患有遠視。在美國和歐洲,預計到2025年底,遠視盛行率將分別達到37.2%和23.1%。
此外,美國疾病管制與預防中心(CDC)於2024年10月報告稱,截至2022年,美國有420萬人患有青光眼,其中150萬人的視力受到影響。患者數量的增加推動了對早期、精準的診斷影像工具(例如眼科超音波系統)的需求。
市場限制因子
設備成本高等替代技術
儘管市場穩定成長,但設備價格高昂(5,500 美元至 20,000 美元不等),這構成了市場挑戰。這限制了低收入和中等收入國家的普及。
此外,光學相干斷層掃描 (OCT)、眼底成像和磁振造影 (MRI) 等替代成像技術的普及也加劇了競爭。例如,2024年6月,日本電產株式會社推出了RS-1,這是一款用於青光眼的OCT系統,具有先進的診斷功能,可以減少對傳統超音波系統的依賴。
市場機會
醫療基礎設施的擴張
新的眼科診所和醫院的開設創造了巨大的成長機會。2024年10月,雪梨眼科醫院開設了Gadigal眼科診所;2024年3月,Optegra眼科診所在英國開業,進一步拓展了眼科醫療服務。
諸如由L.V. Prasad 眼科研究所進一步支持早期診斷,並在全球推廣相關設備的使用。
市場趨勢
技術創新與便攜式設備
一個主要的市場趨勢是便攜式、技術先進的超音波設備的普及率不斷提高。 2024 年 5 月,Quantel Medical 推出了 Pocket III 便攜式超音波角膜厚度分析儀,進一步拓展了便攜式診斷解決方案。
此外,3D 影像技術的應用也不斷成長,從而提升了可視化效果和手術規劃能力。 Sonomed Escalon 等公司正在推出整合式 3D 超音波系統,以提高診斷準確性。
依產品分類
設備細分市場憑藉著不斷湧現的新產品和技術進步,引領市場發展。隨著眼科手術中配件使用量的增加,配件市場也穩定成長。
依裝置類型
便攜式設備市場預計將實現最高成長,這得益於其便利性、易用性和成本效益。推車式系統在醫院環境中持續成長,而手持式設備在門診環境中也越來越受歡迎。
依成像類型
受可視化效果提升和診斷結果增強的推動,3D成像市場預計將在2034年之前保持最高的複合年增長率。 2D成像市場由於其價格實惠和廣泛應用,仍佔較大的市場佔有率。
依最終使用者
由於新診所數量的增加,眼科診所預計將實現最高的複合年增長率。由於診斷程序量龐大,醫院仍將是主要市場組成部分。
北美
預計到2025年,北美市場規模將達到1.2859億美元,佔42.34%的市佔率。先進的醫療保健體系和較高的健康意識是該地區的優勢。
歐洲
歐洲將佔第二大市場規模,這得益於眼科診所的擴張和強勁的醫療保健資金投入。
亞太地區
預計到2034年,亞太地區將以最高的複合年增長率成長,這主要得益於監管審批的增加和醫療保健投資的擴大。 2024年5月,ArcScan Insight 100獲得中國國家藥品監督管理局(NMPA)的批准,進一步推動了該地區的成長。
拉丁美洲、中東和非洲
由於眼科疾病宣傳活動的增加和眼科疾病盛行率的上升,預計這些地區將保持穩定成長。
The global ophthalmic ultrasound market size was valued at USD 303.73 million in 2025. The market is projected to grow from USD 325.19 million in 2026 to USD 578.55 million by 2034, exhibiting a CAGR of 7.47% during the forecast period (2026-2034). North America dominated the global ophthalmic ultrasound market with a 42.34% market share in 2025, driven by advanced healthcare infrastructure and rising prevalence of eye disorders.
Ophthalmic ultrasound devices are specialized diagnostic imaging systems that use high-frequency sound waves to visualize internal eye structures such as the retina, vitreous humor, anterior segment, and orbit. These devices are essential for diagnosing conditions such as glaucoma, diabetic retinopathy, macular degeneration, vitreous hemorrhage, and retinal detachment.
Market Drivers
Growing Prevalence of Eye Disorders
The increasing burden of ophthalmic diseases is a primary driver of market growth. According to data published in March 2025, approximately 30.6% of adults globally are expected to suffer from hyperopia by the end of 2025. In America and Europe, hyperopia prevalence is projected to reach 37.2% and 23.1%, respectively, by the end of 2025.
Additionally, the CDC reported in October 2024 that 4.2 million people in the U.S. were living with glaucoma in 2022, including 1.5 million with vision-affecting glaucoma. The increasing patient population is fueling demand for early and accurate diagnostic imaging tools such as ophthalmic ultrasound systems.
Market Restraints
High Cost of Devices and Alternative Technologies
Despite steady growth, the market faces challenges due to the high cost of devices, ranging between USD 5,500 and USD 20,000. This limits adoption in low- and middle-income countries.
Moreover, the availability of alternative imaging technologies such as Optical Coherence Tomography (OCT), fundus imaging, and MRI presents competitive pressure. For instance, in June 2024, NIDEK CO., LTD. launched the RS-1 Glaucoma OCT system, offering advanced diagnostic capabilities, which may reduce reliance on traditional ultrasound systems.
Market Opportunities
Expansion of Healthcare Infrastructure
The opening of new ophthalmic clinics and hospitals is creating significant growth opportunities. In October 2024, Sydney Eye Hospital launched the Gadigal Eye Clinic, and in March 2024, Optegra Eye Clinic opened in England to enhance ophthalmic services.
Awareness initiatives such as Glaucoma Awareness Week (March 8-16, 2025) organized by L.V. Prasad Eye Institute are further supporting early diagnosis, boosting device utilization globally.
Market Trends
Technological Advancements and Portable Devices
A major market trend is the increasing adoption of portable and technologically advanced ultrasound devices. In May 2024, Quantel Medical launched Pocket III, a handheld ultrasound pachymeter, expanding portable diagnostic solutions.
Additionally, the adoption of 3D imaging technology is rising, offering improved visualization and surgical planning capabilities. Companies such as Sonomed Escalon are introducing integrated 3D ultrasound systems to enhance diagnostic precision.
By Product
The device segment dominates the market due to increasing product launches and technological advancements. Accessories are also growing steadily due to increased usage during ophthalmic surgeries.
By Device Type
The portable segment is expected to witness the highest growth due to convenience, accessibility, and cost-effectiveness. Cart-based systems continue to grow in hospital settings, while hand-held devices are gaining popularity for outpatient care.
By Imaging Type
The 3D imaging segment is projected to grow at the highest CAGR through 2034, driven by enhanced visualization and improved diagnostic outcomes. The 2D imaging segment continues to hold a significant share due to affordability and widespread use.
By End-user
Ophthalmic clinics are expected to grow at the highest CAGR due to increasing clinic openings. Hospitals remain a major segment due to the high volume of diagnostic procedures.
North America
North America generated USD 128.59 million in 2025 and held a 42.34% market share. The region benefits from advanced healthcare systems and high awareness levels.
Europe
Europe represents the second-largest market, supported by expanding ophthalmology clinics and strong healthcare funding.
Asia Pacific
Asia Pacific is projected to grow at the highest CAGR through 2034 due to increasing regulatory approvals and healthcare investments. In May 2024, ArcScan Insight 100 received NMPA approval in China, strengthening regional growth.
Latin America & Middle East & Africa
These regions are expected to grow steadily due to increasing awareness campaigns and rising ocular disease prevalence.
Competitive Landscape
Key players operating in the global ophthalmic ultrasound market include:
Companies are focusing on partnerships, facility expansions, and product innovations. For instance, in February 2025, Keeler launched a new manufacturing facility in Shanghai, China, expanding its global footprint.
Conclusion
The global ophthalmic ultrasound market, valued at USD 303.73 million in 2025, is set to reach USD 578.55 million by 2034, growing at a CAGR of 7.47%. Growth is primarily driven by the rising prevalence of eye disorders, technological advancements, increasing healthcare infrastructure, and expanding awareness initiatives. While high device costs and alternative diagnostic technologies pose challenges, ongoing innovation, portable device adoption, and regional expansion strategies are expected to sustain steady market growth through 2034.
Segmentation By Product
By Device Type
By Imaging Type
By End-user
By Region